Psychedelic Use & Motives Among US Young Adults

Prevalence of Psychedelic Use Among Young Adults

A recent study published in OpenAlex investigates the prevalence and motives behind psychedelic use among young adults in the United States. The study found that 27.7% of participants reported lifetime psychedelic use, with 11.9% using psychedelics in the past year. Common substances included psilocybin, MDMA, and LSD. Notably, 48.8% of users consumed psychedelics for nonmedical purposes, underscoring a significant trend in recreational use among this demographic.

Sociodemographic and Mental Health Correlates

The study utilized multivariable regression to explore the sociodemographic and mental health factors associated with psychedelic use. Key findings indicated that lifetime psychedelic use was more prevalent among older, male, Black, and metropolitan/urban individuals. Additionally, individuals with more depressive symptoms and adverse childhood events (ACEs) were more likely to have used psychedelics. Microdosing was linked to higher anxiety symptoms and ACEs, particularly among those without children.

Motives for Psychedelic Use

Motives for psychedelic use varied significantly across different sociodemographic groups. Those with higher expansion motives tended to be male, White, and exhibited more anxiety symptoms and ACEs. Conversely, individuals with higher mood or social enhancement motives often had more depressive symptoms. The study also noted that symptom management motives were more common among males, Hispanics, and those with depressive symptoms and ACEs. These findings suggest that mental health factors play a crucial role in shaping the motives for psychedelic use.

Implications for Policy and Research

The insights from this study have important implications for policy and research. Understanding the sociodemographic and mental health correlates of psychedelic use can inform targeted interventions aimed at reducing potential adverse outcomes. Policymakers and healthcare providers should consider these factors when developing strategies to address the nonmedical use of psychedelics. Additionally, further research is needed to explore the long-term effects of psychedelic use and microdosing, particularly among young adults with mental health symptoms and ACEs.

Risks and Unknowns

Despite the growing interest in psychedelics, there are several risks and unknowns associated with their use. The study highlights the association between mental health symptoms, ACEs, and psychedelic use, raising concerns about the potential for adverse outcomes. Moreover, the nonmedical use of psychedelics can lead to unpredictable effects and legal complications. It is crucial for future research to address these risks and explore the mechanisms underlying the relationship between mental health and psychedelic use.

Looking Ahead

As interest in psychedelics continues to grow, it is essential to develop a comprehensive understanding of their use among young adults. This study provides valuable insights into the sociodemographic and mental health factors associated with psychedelic use, highlighting the need for targeted interventions and further research. By addressing the risks and unknowns associated with psychedelic use, stakeholders can better support young adults in navigating the complex landscape of psychedelic substances.